Amphotericine B, Liposome

4 trials 2 recruiting JAnti-infectives

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

6 Countries

Phase III

Phase II

Phase III: 3 Phase II: 1

Indications tested

Fungal infection 2

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Nantes 1 Elion Therapeutics Inc. 1 F2G Limited 1

All trials

4 total

CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Phase 2 EL219 versus Liposomal Amphotericin B for Early Antifungal Therapy Recruiting

2025-522835-32-00 Phase II 4 countries Elion Therapeutics Inc.
CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole al… Recruiting

2024-517004-11-00 Phase III 1 country Centre Hospitalier Universitaire De Poitiers
A study to evaluate the efficacy and safety of olorofim versus AmBisome® for treatment of invasive aspergillosis Ended

2024-513030-38-00 Phase III 6 countries F2G Limited

Showing 1–4 of 4 trials

← All drugs A–Z